Judith Finlay, PhD
About Judith Finlay, PhD
Judith Finlay, PhD, is a Clinical Research Scientist at Novocure in San Diego, California, with extensive experience in medical science liaison roles and a strong background in biochemistry and cancer diagnostics.
Current Role at Novocure
Judith Finlay, PhD, currently serves as a Clinical Research Scientist at Novocure in San Diego, California. In her role, she is the North American Lead Clinical Research Scientist for the Panova-3 pivotal trial, which focuses on patients with locally advanced unresectable pancreatic cancer. She leads a team of Clinical Research Scientists who engage site staff, including principal investigators, to elucidate the mechanism of action of tumor treating fields and the details of the protocol for the Panova-3 clinical trial.
Past Experience at G1 Therapeutics and IQVIA
In 2019, Judith Finlay worked briefly as a Medical Science Liaison - West at G1 Therapeutics, Inc. She held a Medical Science Liaison position at IQVIA from 2019 to 2020, where she was contracted out to G1 Therapeutics. During her tenure, she helped facilitate the development of trilaciclib, a medication granted FDA breakthrough designation, designed to protect hematopoietic stem and progenitor cells during myelosuppressive chemotherapy.
Roles at The Medical Affairs Company and PRA Health Sciences
From 2017 to 2019, Judith Finlay served as a Medical Science Liaison at The Medical Affairs Company, where she worked with Jounce Therapeutics, focusing on immuno-oncology. Prior to that, she was a Clinical Trial Liaison at PRA Health Sciences from 2016 to 2017, where she engaged physicians and other stakeholders by explaining the scientific basis of clinical trials.
Director of Scientific Affairs at The Binding Site
Judith Finlay worked as the Director of Scientific Affairs at The Binding Site from 2008 to 2015. In this position, she concentrated on multiple myeloma and plasma cell disorders. Her role involved advancing the scientific understanding of these disease areas and engaging with the medical community to disseminate critical information related to the clinical implications and diagnostics.
Educational Background and Early Career
Judith Finlay holds a PhD in Biochemistry from the University of Wisconsin-Madison and a BA in Chemistry from Wells College. Her early career includes significant roles such as Principal Scientist at Beckman Coulter from 1996 to 2004, and Senior Scientist at Hybritech Incorporated from 1993 to 1996. In these roles, she gained substantial experience in developing scientific assays and product development, focusing chiefly on biomarker research and cancer diagnostics.